Predictive Effect of Neuroinflammatory Factors of the MECT in Treatment of Senile Depression
Predictive Effect of Neuroinflammatory Factors on the Efficacy of Modified Electroconvulsive Therapy in the Treatment of Senile Depression Accompanied by Suicidal Ideation
Sponsor: Qinge Zhang
A observational or N/A phase clinical study on Major Depression Disorder, this trial is ongoing. The trial is conducted by Qinge Zhang and has accumulated 4 data snapshots since 2021. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
4 versions recorded-
Nov 2024 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Nov 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Nov 2022 — Jul 2024 [monthly]
Recruiting
First recorded
Jun 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Qinge Zhang
For direct contact, visit the study record on ClinicalTrials.gov .